These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Properties of N-hydroxy-N'-aminoguanidine derivatives as inhibitors of mammalian ribonucleotide reductase. Weckbecker G; Lien EJ; Cory JG Biochem Pharmacol; 1988 Feb; 37(3):529-34. PubMed ID: 3276327 [TBL] [Abstract][Full Text] [Related]
24. Effect of iron-chelating agents on inhibitors of ribonucleotide reductase. Cory JG; Lasater L; Sato A Biochem Pharmacol; 1981 May; 30(9):979-84. PubMed ID: 6786297 [No Abstract] [Full Text] [Related]
25. Inhibition of nucleic acid synthesis in Ehrlich tumor cells by periodate-oxidized adenosine and adenylic acid. Cory JG; Mansell MM; George CB; Wilkinson DS Arch Biochem Biophys; 1974 Feb; 160(2):495-503. PubMed ID: 4364771 [No Abstract] [Full Text] [Related]
26. Dinucleotide analogues as inhibitors of thymidine kinase, thymidylate kinase, and ribonucleotide reductase. Davies LC; Stock JA; Barrie SE; Orr RM; Harrap KR J Med Chem; 1988 Jul; 31(7):1305-8. PubMed ID: 2838631 [TBL] [Abstract][Full Text] [Related]
27. Studies on ribonucleoside-diphosphate reductase in permeable animal cells. II. Catalytic and regulatory properties of the enzyme in mouse L cells. Kucera R; Paulus H Arch Biochem Biophys; 1982 Mar; 214(1):114-23. PubMed ID: 6177289 [No Abstract] [Full Text] [Related]
28. Effects of the ferrous chelate of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIQ-1) on the kinetics of reduction of CDP by ribonucleotide reductase of the Novikoff tumor. Preidecker PJ; Agrawal KC; Sartorelli AC; Moore EC Mol Pharmacol; 1980 Nov; 18(3):507-12. PubMed ID: 7007866 [No Abstract] [Full Text] [Related]
29. Mechanism of inactivation of Escherichia coli ribonucleotide reductase by 2'-chloro-2'-deoxyuridine 5'-diphosphate: evidence for generation of a 2'-deoxy-3'-ketonucleotide via a net 1,2 hydrogen shift. Ator MA; Stubbe J Biochemistry; 1985 Dec; 24(25):7214-21. PubMed ID: 3910098 [TBL] [Abstract][Full Text] [Related]
30. Is ribonucleotide reductase in Ehrlich ascites mammary tumour cells the target of a growth inhibitor purified from bovine mammary gland? Langen P; Lehmann W; Graetz H; Böhmer FD; Grosse R Biomed Biochim Acta; 1984; 43(12):1377-83. PubMed ID: 6398699 [TBL] [Abstract][Full Text] [Related]
31. Quenching of tyrosine radicals of M2 subunit from ribonucleotide reductase in tumor cells by different antitumor agents: an EPR study. Liermann B; Lassmann G; Langen P Free Radic Biol Med; 1990; 9(1):1-4. PubMed ID: 2170241 [TBL] [Abstract][Full Text] [Related]
32. Ribonucleotide reductases: radical chemistry and inhibition at the active site. Robins MJ Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):519-34. PubMed ID: 14565227 [TBL] [Abstract][Full Text] [Related]
33. Effects of nucleoside triphosphates on human ribonucleotide reductase from Molt-4F cells. Chang CH; Cheng YC Cancer Res; 1979 Dec; 39(12):5087-92. PubMed ID: 498136 [No Abstract] [Full Text] [Related]
34. ESR studies on reactivity of protein-derived tyrosyl radicals formed by prostaglandin H synthase and ribonucleotide reductase. Lassmann G; Curtis J; Liermann B; Mason RP; Eling TE Arch Biochem Biophys; 1993 Jan; 300(1):132-6. PubMed ID: 8380961 [TBL] [Abstract][Full Text] [Related]
35. Ribonucleotide reductase: association of the regulatory subunit in the presence of allosteric effectors. Klippenstein GL; Cory JG Biochem Biophys Res Commun; 1978 Jul; 83(1):252-8. PubMed ID: 697814 [No Abstract] [Full Text] [Related]
36. Role of ribonucleotide reductase in expression in the neoplastic program. Takeda E; Weber G Life Sci; 1981 Mar; 28(9):1007-14. PubMed ID: 7012518 [No Abstract] [Full Text] [Related]
37. Nucleotide and thioredoxin specificity of the manganese ribonucleotide reductase from Brevibacterium ammoniagenes. Willing A; Follmann H; Auling G Eur J Biochem; 1988 Jul; 175(1):167-73. PubMed ID: 3042394 [TBL] [Abstract][Full Text] [Related]
38. Studied on ribonucleoside-diphosphate reductase in permeable animal cells. I. Reversible permeabilization of mouse L cells with dextran sulfate. Kucera R; Paulus H Arch Biochem Biophys; 1982 Mar; 214(1):102-13. PubMed ID: 6177288 [No Abstract] [Full Text] [Related]
39. Fluorinated pyrimidines. XL. The reduction of 5-fluorouridine 5'-diphosphate by ribonucleotide reductase. Kent RJ; Heidelberger C Mol Pharmacol; 1972 Jul; 8(4):465-75. PubMed ID: 5053584 [No Abstract] [Full Text] [Related]
40. Diphosphopyridine nucleotide specific isocitric dehydrogenase of mammalian mitochondria. II. Kinetic properties of the enzyme of the Ehrlich ascites carcinoma. Stein AM; Kirkman SK; Stein JH Biochemistry; 1967 Oct; 6(10):3197-203. PubMed ID: 4293542 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]